FDA Approves New Animal Drug Dosage Forms for Estradiol Benzoate and Testosterone Propionate

Summary

The FDA has amended its regulations to reflect the approval of new animal drug applications for subcutaneous implants containing estradiol benzoate and testosterone propionate, with specific warnings against their use in calves destined for veal production.